why choose us

Clinical Trials Search

Showing 4,910 of 132,963 result(s)
Efficacy and Safety of Early Initiation of Butylphthalide Treatment in Patients With Acute Ischemic Stroke.

Status: COMPLETED

Condition: Acute Ischemic Stroke

Interventions: Eligible participants with acute ischemic stroke will be randomly assigned in a 1:1 ratio to two groups: an early initiation group (<3 hours) a

Date: 2024-06-19

Muscle-tendon Interaction in the Spastic Sural Triceps During Gait

Status: COMPLETED

Condition: Spinal Cord Injuries

Interventions: Measure the lengths of the Achilles tendon and gastrocnemius medialis muscle

Date: 2024-06-19

Hysterectomy With Adnexal Surgery Procedures With the DEXTER Robotic System (The HYPER Study)

Status: COMPLETED

Condition: Hysterectomy

Interventions: Robotic-assisted and laparoscopic hysterectomy with adnexal surgery for benign disease.

Date: 2024-06-19

A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET

Status: COMPLETED

Condition: Major Depressive Disorder

Interventions: oral

Date: 2024-06-18

A Study of TAK-861 for the Treatment of Narcolepsy Type 1

Status: COMPLETED

Condition: Narcolepsy Type 1

Interventions: Oral tablet.

Date: 2024-06-18

A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis

Status: COMPLETED

Condition: Generalized Myasthenia Gravis

Interventions: Zilucoplan will be self-administered subcutaneously by study participants at pre-specified time points.

Date: 2024-06-18

Auditory-Cognitive Dual-Task Intervention for Older Adults With Hearing Loss

Status: COMPLETED

Condition: Age-related Hearing Loss

Interventions: The components of auditory training are designed based on an auditory training and aural rehabilitation program LACETM (Listening & Communication

Date: 2024-06-18

Impact of Intermittent Fasting and Mediterranean Diet on the Physical Health of the Elderly

Status: COMPLETED

Condition: Diabetes

Interventions: 8 participants who practiced a 12;12 TRF (12 hours of fasting, from approximately 20:30 to 8:30 the following day).

Date: 2024-06-17

Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor

Status: COMPLETED

Condition: Germ Cell Tumor

Interventions: The oral dose of thalidomide is 1.5-2.5mg;kg;d
daily (maximum 28g).
Each cycle lasts for 21 days (every three weeks), and if treat

Date: 2024-06-17